ProKidney (MEX:PROK) Interest Expense : MXN-0.17 Mil (TTM As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProKidney Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. ProKidney's interest expense for the three months ended in Jun. 2024 was MXN -0.06 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was MXN-0.17 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. ProKidney's Operating Income for the three months ended in Jun. 2024 was MXN -788.79 Mil. ProKidney's Interest Expense for the three months ended in Jun. 2024 was MXN -0.06 Mil. ProKidney did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ProKidney Interest Expense Historical Data

The historical data trend for ProKidney's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Interest Expense Chart

ProKidney Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Expense

-4.19

-0.20

ProKidney Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Interest Expense	Get a 7-Day Free Trial										-0.07	-0.04	-0.05	-0.03	-0.06

ProKidney Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-0.17 Mil.

ProKidney (MEX:PROK) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ProKidney's Interest Expense for the three months ended in Jun. 2024 was MXN-0.06 Mil. Its Operating Income for the three months ended in Jun. 2024 was MXN-788.79 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2024 was MXN103.33 Mil.

ProKidney's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

ProKidney did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

ProKidney Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

PROK:USA

Address

2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103

Website

https://www.prokidney.com

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.